160 related articles for article (PubMed ID: 27500339)
41. Gynecologic Surgical Subspecialty Training Decreases Surgical Complications in Benign Minimally Invasive Hysterectomy.
Pfeuti CK; Makai G
J Minim Invasive Gynecol; 2024 Mar; 31(3):250-257. PubMed ID: 38151094
[TBL] [Abstract][Full Text] [Related]
42. Robotic Hysterectomy for Benign Indications: What Have We Learned from a Decade?
Carbonnel M; Moawad GN; Tarazi MM; Revaux A; Kennel T; Favre-Inhofer A; Ayoubi JM
JSLS; 2021; 25(1):. PubMed ID: 33879990
[TBL] [Abstract][Full Text] [Related]
43. Venous Thromboembolism After Blood Transfusions in Women Undergoing Hysterectomy for Non-Malignant Indications: A Retrospective Cohort Study.
Sedra S; Mallick R; Nayak AL; Choudhry AJ; Bougie O; Singh SS; Arendas K; Saidenberg E; Schramm DR; Chen I
J Obstet Gynaecol Can; 2021 Feb; 43(2):167-174. PubMed ID: 33229282
[TBL] [Abstract][Full Text] [Related]
44. Complication Rates and Outcomes After Hysterectomy in Transgender Men.
Bretschneider CE; Sheyn D; Pollard R; Ferrando CA
Obstet Gynecol; 2018 Nov; 132(5):1265-1273. PubMed ID: 30303922
[TBL] [Abstract][Full Text] [Related]
45. Assessing the impact of obesity on surgical quality outcomes among patients undergoing hysterectomy for benign, non-urgent indications.
Cybulsky M; Murji A; Sunderji Z; Shapiro J; Elliott C; Shirreff L
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():243-250. PubMed ID: 35688107
[TBL] [Abstract][Full Text] [Related]
46. A bundled intervention lowers surgical site infection in hysterectomy for benign and malignant indications.
Guo XM; Runge M; Miller D; Aaby D; Milad M
Int J Gynaecol Obstet; 2020 Sep; 150(3):392-397. PubMed ID: 32506459
[TBL] [Abstract][Full Text] [Related]
47. Risk Factors for Emergency Department Visits After Hysterectomy for Benign Disease.
Mahnert N; Kamdar N; Lim CS; Skinner B; Hassett A; Kocher KE; Morgan DM; As-Sanie S
Obstet Gynecol; 2017 Aug; 130(2):296-304. PubMed ID: 28697116
[TBL] [Abstract][Full Text] [Related]
48. Effect of postoperative partial bladder filling after minimally invasive hysterectomy on postanesthesia care unit discharge and cost: a single-blinded, randomized controlled trial.
Moawad G; Tyan P; Marfori C; Abi Khalil E; Park D
Am J Obstet Gynecol; 2019 Apr; 220(4):367.e1-367.e7. PubMed ID: 30639089
[TBL] [Abstract][Full Text] [Related]
49. Benign Hysterectomy Operative Times and 30-Day Complications: A Cohort Study.
Ikoma D; Ikoma M; Gnade C; Haugsdal M
J Minim Invasive Gynecol; 2022 Mar; 29(3):429-439. PubMed ID: 34808382
[TBL] [Abstract][Full Text] [Related]
50. Resident participation in laparoscopic hysterectomy: impact of trainee involvement on operative times and surgical outcomes.
Igwe E; Hernandez E; Rose S; Uppal S
Am J Obstet Gynecol; 2014 Nov; 211(5):484.e1-7. PubMed ID: 24949539
[TBL] [Abstract][Full Text] [Related]
51. Advanced Training of Gynecologic Surgeons and Incidence of Intraoperative Complications after Total Laparoscopic Hysterectomy: A Retrospective Study of More Than 2000 Cases at a Single Institution.
McDonnell RM; Hollingworth JL; Chivers P; Cohen PA; Salfinger SG
J Minim Invasive Gynecol; 2018; 25(5):810-815. PubMed ID: 29253636
[TBL] [Abstract][Full Text] [Related]
52. Extent of lymphadenectomy and postoperative major complications among women with endometrial cancer treated with minimally invasive surgery.
Polan RM; Rossi EC; Barber EL
Am J Obstet Gynecol; 2019 Mar; 220(3):263.e1-263.e8. PubMed ID: 30521798
[TBL] [Abstract][Full Text] [Related]
53. Risk Factors for Unscheduled 30-day Readmission after Benign Hysterectomy.
Catanzarite T; Vieira B; Qin C; Milad MP
South Med J; 2015 Sep; 108(9):524-30. PubMed ID: 26332476
[TBL] [Abstract][Full Text] [Related]
54. An audit on hysterectomy for benign diseases in public hospitals in Hong Kong.
Leung PL; Tsang SW; Yuen PM;
Hong Kong Med J; 2007 Jun; 13(3):187-93. PubMed ID: 17548906
[TBL] [Abstract][Full Text] [Related]
55. The effect of anemia severity on postoperative morbidity among patients undergoing laparoscopic hysterectomy for benign indications.
Tyan P; Taher A; Carey E; Sparks A; Radwan A; Amdur R; Tamim H; Gu A; Robinson H; Moawad GN
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):112-118. PubMed ID: 31449328
[TBL] [Abstract][Full Text] [Related]
56. Delayed recognition of lower urinary tract injuries following hysterectomy for benign indications: A NSQIP-based study.
Bretschneider CE; Casas-Puig V; Sheyn D; Hijaz A; Ferrando CA
Am J Obstet Gynecol; 2019 Aug; 221(2):132.e1-132.e13. PubMed ID: 30926265
[TBL] [Abstract][Full Text] [Related]
57. Hysterectomy for benign conditions in a university hospital in Saudi Arabia.
Sait K; Alkhattabi M; Boker A; Alhashemi J
Ann Saudi Med; 2008; 28(4):282-6. PubMed ID: 18596405
[TBL] [Abstract][Full Text] [Related]
58. Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals.
David-Montefiore E; Rouzier R; Chapron C; Daraï E;
Hum Reprod; 2007 Jan; 22(1):260-5. PubMed ID: 16950826
[TBL] [Abstract][Full Text] [Related]
59. Association between obesity and the trends of routes of hysterectomy performed for benign indications.
Mikhail E; Miladinovic B; Velanovich V; Finan MA; Hart S; Imudia AN
Obstet Gynecol; 2015 Apr; 125(4):912-918. PubMed ID: 25751208
[TBL] [Abstract][Full Text] [Related]
60. Factors associated with 30-day hospital readmission after hysterectomy.
Dessources K; Hou JY; Tergas AI; Burke WM; Ananth CV; Prendergast E; Chen L; Neugut AI; Hershman DL; Wright JD
Obstet Gynecol; 2015 Feb; 125(2):461-470. PubMed ID: 25569007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
